Sanders GD - Search Results

1

Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection.

Holland DP, Sanders GD, Hamilton CD, Stout JE. Holland DP, et al. Among authors: sanders gd. Am J Respir Crit Care Med. 2009 Jun 1;179(11):1055-60. doi: 10.1164/rccm.200901-0153OC. Epub 2009 Mar 19. Am J Respir Crit Care Med. 2009. PMID: 19299495 Free PMC article.

2

Potential economic viability of two proposed rifapentine-based regimens for treatment of latent tuberculosis infection.

Holland DP, Sanders GD, Hamilton CD, Stout JE. Holland DP, et al. Among authors: sanders gd. PLoS One. 2011;6(7):e22276. doi: 10.1371/journal.pone.0022276. Epub 2011 Jul 18. PLoS One. 2011. PMID: 21789248 Free PMC article.

3

Strategies for treating latent multiple-drug resistant tuberculosis: a decision analysis.

Holland DP, Sanders GD, Hamilton CD, Stout JE. Holland DP, et al. Among authors: sanders gd. PLoS One. 2012;7(1):e30194. doi: 10.1371/journal.pone.0030194. Epub 2012 Jan 17. PLoS One. 2012. PMID: 22272302 Free PMC article.

4

An economic evaluation of prolonged mechanical ventilation.

Cox CE, Carson SS, Govert JA, Chelluri L, Sanders GD. Cox CE, et al. Among authors: sanders gd. Crit Care Med. 2007 Aug;35(8):1918-27. doi: 10.1097/01.CCM.0000275391.35834.10. Crit Care Med. 2007. PMID: 17581479 Free PMC article.

5

Cost-effectiveness of HIV screening in patients older than 55 years of age.

Sanders GD, Bayoumi AM, Holodniy M, Owens DK. Sanders GD, et al. Ann Intern Med. 2008 Jun 17;148(12):889-903. doi: 10.7326/0003-4819-148-12-200806170-00002. Ann Intern Med. 2008. PMID: 18559840 Free PMC article.

6

Cost-effectiveness of strategies to improve HIV testing and receipt of results: economic analysis of a randomized controlled trial.

Sanders GD, Anaya HD, Asch S, Hoang T, Golden JF, Bayoumi AM, Owens DK. Sanders GD, et al. J Gen Intern Med. 2010 Jun;25(6):556-63. doi: 10.1007/s11606-010-1265-5. Epub 2010 Mar 4. J Gen Intern Med. 2010. PMID: 20204538 Free PMC article. Clinical Trial.

7

Cost-effectiveness of implantable cardioverter-defibrillators.

Sanders GD, Hlatky MA, Owens DK. Sanders GD, et al. N Engl J Med. 2005 Oct 6;353(14):1471-80. doi: 10.1056/NEJMsa051989. N Engl J Med. 2005. PMID: 16207849 Free article.

8

Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.

Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, Rydzak CE, Douglass LR, Lazzeroni LC, Holodniy M, Owens DK. Sanders GD, et al. N Engl J Med. 2005 Feb 10;352(6):570-85. doi: 10.1056/NEJMsa042657. N Engl J Med. 2005. PMID: 15703422 Free article.

9

Cost-effectiveness of testing for hypercoagulability and effects on treatment strategies in patients with deep vein thrombosis.

Auerbach AD, Sanders GD, Hambleton J. Auerbach AD, et al. Among authors: sanders gd. Am J Med. 2004 Jun 15;116(12):816-28. doi: 10.1016/j.amjmed.2004.01.017. Am J Med. 2004. PMID: 15178497 Review.

10

Cost-effectiveness of implantable cardioverter defibrillators in patients >or=65 years of age.

Sanders GD, Kong MH, Al-Khatib SM, Peterson ED. Sanders GD, et al. Am Heart J. 2010 Jul;160(1):122-31. doi: 10.1016/j.ahj.2010.04.021. Am Heart J. 2010. PMID: 20598982

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

211 results

Search Page